Search
Search Results
-
Raman Spectroscopy as a Potential Tool to Analyze Alzheimer’s Disease Progression
Alzheimer’s disease (AD) is a neurodegenerative disorder that affects cognition, function, and behaviour of a person’s daily activity which is...
-
Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer’s Disease: A Review
PurposeAlzheimer’s disease (AD) is regarded as the most common neurological condition in terms of cognition. The disease progresses gradually, begin...
-
Gold nanoparticles with amyloid-β reduce neurocell cytotoxicity for the treatment and care of Alzheimer’s disease therapy
Protein oligomerization contributes to Alzheimer’s disease development (AD). A nanoparticle that can speed up the oligomerization of proteins is...
-
Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease
BackgroundAlzheimer’s disease is a neurodegenerative disorder, and Aβ aggregation is considered to be the central process implicated in its...
-
Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer’s disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay
Phosphorylation of tau at Ser (396, 404) (p-tau 396,404 ) is one of the earliest phosphorylation events, and plasma p-tau 396,404 level appears to be a...
-
Develop potential multi-target drugs by self-assembly of quercetin with amino acids and metal ion to achieve significant efficacy in anti-Alzheimer’s disease
Exploring multi-target drugs (MTDs) is a prevalent method against Alzheimer’s disease (AD). However, the current developed MTDs based on the...
-
Computational Validation and Nanofabrication of Withania Somifera Extract for CNS Targeting Against Alzheimer’s Disease
The prevalence and distribution of Central nervous system (CNS) disorders are increasing globally until 2021. It was estimated that 55 million people...
-
Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosis
Backgroundβ-Secretase (BACE1) is the vital enzyme in the pathogenic processes of Alzheimer's disease (AD). However, the development of a powerful...
-
The impacts of curcumin on learning memory function in Alzheimer’s disease under the poly lactic-co-glycolic acid nanoparticle drug carrier
To analyze the treatment effect of the curcumin nanoparticle drug delivery system to the Alzheimer’s disease (AD), the NP-Cur, NP-S1-Cur, and...
-
Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease clinically characterized by progressive loss of memory, impairment cognitive...
-
Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease
AbstractAlzheimer's disease (AD) is one of the most common forms of dementia, affecting more than 50 million people globally. The onset of AD is...
-
Innovative Web Application Revolutionizing Disease Detection, Empowering Users and Ensuring Accurate Diagnosis
This paper presents an innovative enhancement aimed at revolutionizing disease detection and providing users with a reliable source of information...
-
-
Recent advances in nanotechnology and its application for neuro-disease: a review
Nanotechnology is an emerging field that is useful for various purposes. Numerous neurological disorders, such as Parkinson's disease (PD),...
-
Targeted Nano-based Drug Delivery in Alzheimer's Disease and Dementia
Alzheimer's disease (AD), the utmost widespread neurodegenerative illness, contributes to an enormous and expanding healthcare burden and impairs...
-
Neuroprotective Potential of Ayurvedic Herbal Extracts: A Promising Avenue in the Therapeutic Management of Alzheimer Disease
Alzheimer’s disease (AD) is a neurological disorder condition that results in the death of brain cells causing dementia, i.e., decline in cognitive...
-
A STIR nucleic acid drug delivery system for stirring phenotypic switch of microglia in Parkinson’s disease treatments
Neuroinflammation is one of the three important pathological features in neurodegenerative diseases including Parkinson’s disease (PD). The...
-
Disease Preventing Bioactivities of Chitooligosaccharides: Current Status and Future Trends
Recent advancements in studies related to Chitooligosaccharides (COS) have focussed on their disease preventing bioactivities. Pharmaceutical and...
-
Presenting a novel approach based on deep learning neural network and using brain images to diagnose Alzheimer's disease
A major symptom of Alzheimer's disease is memory impairment, which is the most prevalent form of dementia. The risk of Alzheimer's disease is...
-
Study of the Neuroprotective Properties of Fullerenol C60(OH)30 with a Model of Alzheimer’s Disease
AbstractAn urgent task of modern medicine is the search for drugs that can stop or slow down the course of neurodegenerative diseases, in particular...
